Madison Adanusa, George Adjei, Sebastian Eliason, Samuel Amoah, Benson Cecil, Ignatius Sirikyi, Faustina Pappoe, Anasthasia Ofori, Frederick Adjei, Bernice Appau, Benjamin Nyane, Arthur Rudolf, Hagan Oheneba
{"title":"加纳一家初级卫生保健机构乙型和丙型肝炎的血清患病率。","authors":"Madison Adanusa, George Adjei, Sebastian Eliason, Samuel Amoah, Benson Cecil, Ignatius Sirikyi, Faustina Pappoe, Anasthasia Ofori, Frederick Adjei, Bernice Appau, Benjamin Nyane, Arthur Rudolf, Hagan Oheneba","doi":"10.4314/ahs.v24i4.5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The advent of emerging global infections such as SARS-CoV-2 has brought forth the public health crises of neglected diseases in the LMICs. Viral hepatitis infections remain a public health problem especially in the advent of emerging. Viral hepatitis which preponderantly afflicts citizens of LMICs is one such group of diseases which exerts considerable burden in these countries, especially, hepatitis B and C. There is an effective vaccine against Hepatitis B and curative treatment to hepatitis C, however, access has been hampered resulting in deleterious sequalae. Identifying population afflicted by these infections could lead to prevention of the complications.</p><p><strong>Materials and methods: </strong>Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated.</p><p><strong>Results: </strong>Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%.</p><p><strong>Conclusion: </strong>The burden of hepatitis B and C infection in Ghana is still high.</p>","PeriodicalId":94295,"journal":{"name":"African health sciences","volume":"24 4","pages":"29-37"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970139/pdf/","citationCount":"0","resultStr":"{\"title\":\"Sero-prevalence of Hepatitis B and C at a Primary Health Care Facility in Ghana.\",\"authors\":\"Madison Adanusa, George Adjei, Sebastian Eliason, Samuel Amoah, Benson Cecil, Ignatius Sirikyi, Faustina Pappoe, Anasthasia Ofori, Frederick Adjei, Bernice Appau, Benjamin Nyane, Arthur Rudolf, Hagan Oheneba\",\"doi\":\"10.4314/ahs.v24i4.5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The advent of emerging global infections such as SARS-CoV-2 has brought forth the public health crises of neglected diseases in the LMICs. Viral hepatitis infections remain a public health problem especially in the advent of emerging. Viral hepatitis which preponderantly afflicts citizens of LMICs is one such group of diseases which exerts considerable burden in these countries, especially, hepatitis B and C. There is an effective vaccine against Hepatitis B and curative treatment to hepatitis C, however, access has been hampered resulting in deleterious sequalae. Identifying population afflicted by these infections could lead to prevention of the complications.</p><p><strong>Materials and methods: </strong>Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated.</p><p><strong>Results: </strong>Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%.</p><p><strong>Conclusion: </strong>The burden of hepatitis B and C infection in Ghana is still high.</p>\",\"PeriodicalId\":94295,\"journal\":{\"name\":\"African health sciences\",\"volume\":\"24 4\",\"pages\":\"29-37\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11970139/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"African health sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4314/ahs.v24i4.5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"African health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/ahs.v24i4.5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sero-prevalence of Hepatitis B and C at a Primary Health Care Facility in Ghana.
Background: The advent of emerging global infections such as SARS-CoV-2 has brought forth the public health crises of neglected diseases in the LMICs. Viral hepatitis infections remain a public health problem especially in the advent of emerging. Viral hepatitis which preponderantly afflicts citizens of LMICs is one such group of diseases which exerts considerable burden in these countries, especially, hepatitis B and C. There is an effective vaccine against Hepatitis B and curative treatment to hepatitis C, however, access has been hampered resulting in deleterious sequalae. Identifying population afflicted by these infections could lead to prevention of the complications.
Materials and methods: Retrospective review of electronic data on individuals screened for hepatitis B and C at the University of Cape Coast Hospital were abstracted. Data abstracted included hepatitis B and C test status, age, sex, previous immunisation history and region of residence. Overall prevalence and prevalence in different categories were calculated.
Results: Data for 6,006 were collected and used for the analyses. The overall prevalence for hepatitis B in the study group was 5.06%. The prevalence for hepatitis C was 0.93%.
Conclusion: The burden of hepatitis B and C infection in Ghana is still high.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
